Analysis of patent information of NCE drugs approved by FDA for rare diseases in 2015QIAN Li-na, CUI Jian2641-2646
Validation of two predictive softwares for the toxicity prediction of chemical ingredients in traditional Chinese medicineSHI Shao-ze, WANG Qi2647-2652
Research of dissolution determination method of dexlansoprazole sustained-release capsulesCHEN Juan, ZHANG Kun, YANG Zhi-qiang, WANG Xing-lin, PAN Feng2659-2663
Study on mechanisms of anaphylactoid reaction induced by Tween 80LI Zhen-hu, WANG Hua-long, LIU Yan-ting, GAO Xiu-mei, XU Yan-tong2664-2669
Selection and identification of severe fever with thrombocytopenia syndrome bunyavirus strain for vaccineproduction戴新宪, 郝春生, 陈蕾, 王潇潇, 刘宇, 吴蕴怡, 马淑花, 支惠, 宁海京2670-2675
Progress in synthesis of lorcaserin hydrochlorideHE Xin, WANG Jun-wei, ZHU Qi-hua, XU Yun-gen2676-2682
Effects of nalbuphine on remifentanil-induced postoperative hyperalgesia and shiveringZHANG Yu, HE Wan-you, LIANG Shun-ping, YANG Cheng-xiang, WANG Han-bing2688-2691
Analysis of problems in clinical informed consentZHAO Shu-hua, LIU Xiao-hong, FU Zhi-ying, JIANG Min2692-2695